Diabetes raises HCC, malignancy risk in hep C patients

10/8/2012 | Healio

Patients with chronic hepatitis C virus infection and type 2 diabetes had a nearly twofold increased risk of developing hepatocellular carcinoma and other malignancies including pancreatic and gastric cancers following interferon therapy, a study showed. However, maintaining mean A1C levels of less than 7.0% was associated with lower HCC risk, researchers reported in the journal Hepatology.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI